Status:
COMPLETED
Efficacy of Low-residue Full Nutritive Formula Powder in Bowel Preparation for Colonoscopy
Lead Sponsor:
Changhai Hospital
Conditions:
Bowel Preparation for Colonoscopy
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Previously, our team compared the effects of a low-residue full nutrition formula podwer (FNFP) combined with 3 liters of polyethylene glycol(PEG) solution and the self-prepared low-residue diet combi...
Eligibility Criteria
Inclusion
- adult subjects between the ages of 18 and 75 who were scheduled for screening, monitoring, and diagnostic colonoscopy.
Exclusion
- severe heart, brain, lung, kidney complications or a history of acute myocardial infarction within six months.
- a history of abdominal or pelvic surgery, BMI \> 28 or BMI \< 18.5, inflammatory bowel disease, constipation (less than 3 bowel movements in the past week, with strenuous bowel movements, hard stool, small volume), or intestinal obstruction.
- imaging and laboratory tests are highly suspicious of colorectal cancer or warning signs and symptoms of colorectal cancer: blood in the stool, black stool, unexplained anemia and significant weight loss, abdominal mass, and positive digital rectal examination.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2025
Estimated Enrollment :
757 Patients enrolled
Trial Details
Trial ID
NCT06514989
Start Date
July 1 2024
End Date
June 20 2025
Last Update
September 11 2025
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Lu'an People's Hospital
Lu'an, Anhui, China
2
PLA 909 Hospital
Quanzhou, Fujian, China
3
PLA 909 Hospital
Zhangzhou, Fujian, China
4
Huizhou Central People's Hospital
Huizhou, Guangdong, China